- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Achillion Pharmaceuticals Inc
Add to PortfolioACHN:US
7.3500 USD 0.0300 0.41%As of 20:10:00 ET on 05/25/2012.
Snapshot for Achillion Pharmaceuticals Inc (ACHN)
| Open: | 7.2800 | Day's Range: | 7.1160 - 7.3500 | Volume: | 396,210 | Bid: | 7.3500 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 7.3200 | 52wk Range: | 3.8100 - 12.9500 | 1-Yr Rtn: | +2.51% | Ask: | 7.3600 |
Key Statistics for ACHN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.6500 |
| Est. EPS (USD) (12/2012) | -0.6470 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 519.25 |
| Shares Outstanding (M) | 70.65 |
| Enterprise Value (M USD) (ttm) | 450.16 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 8.1182 |
| Price/Sale (ttm) | 192.8807 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/08/2012 |
More ACHN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ACHN
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for ACHN
Achillion Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops solutions for infectious diseases such as HIV, hepatitis, and resistant bacterial infections.
| Michael D KishbauchPresident/CEO | Milind S DeshpandePresident:Research & Dev |
| Mary Kay FentonSenior VP/CFO | Elizabeth A OlekSenior VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page